These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3944192)

  • 1. Rat fibroblasts expressing high levels of human c-myc transcripts are anchorage-independent and tumorigenic.
    Pellegrini S; Basilico C
    J Cell Physiol; 1986 Jan; 126(1):107-14. PubMed ID: 3944192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of an exogenous c-myc gene is insufficient for transformation and tumorigenic conversion of established fibroblasts.
    Zerlin M; Julius MA; Cerni C; Marcu KB
    Oncogene; 1987 Mar; 1(1):19-27. PubMed ID: 3325875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
    Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
    Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfected neu oncogene induces human prostate cancer metastasis.
    Zhau HY; Zhou J; Symmans WF; Chen BQ; Chang SM; Sikes RA; Chung LW
    Prostate; 1996 Feb; 28(2):73-83. PubMed ID: 8604395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse fibroblasts transformed with the human c-myc gene express a high level of mRNA but a low level of c-myc protein and are non-tumorigenic in nude mice.
    Ray R; Thomas S; Miller DM
    Oncogene; 1989 May; 4(5):593-600. PubMed ID: 2657574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumorigenic transformation of rat FR3T3 fibroblasts carrying an activated myc oncogene requires subsequent mutational events.
    Mougneau E; Cerni C; Tillier F; Cuzin F
    Oncogene Res; 1988; 2(2):177-88. PubMed ID: 3217111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription of the c-myc oncogene is altered in spontaneously immortalized rodent fibroblasts.
    Tavassoli M; Shall S
    Oncogene; 1988 Apr; 2(4):337-45. PubMed ID: 3283652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transformation of rodent immortalized and embryo cells by oncogenes. II. Rat embryo fibroblasts (REF).
    Denner J; Jandrig B; Ehm I; Schramm T
    Arch Geschwulstforsch; 1987; 57(6):475-85. PubMed ID: 3435226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification, rearrangements, and enhanced expression of c-myc in chemically induced rat liver tumors in vivo and in vitro.
    Suchy BK; Sarafoff M; Kerler R; Rabes HM
    Cancer Res; 1989 Dec; 49(23):6781-7. PubMed ID: 2684400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C; Chen N; Sawadogo M
    Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of c-myc expression in a human hepatoma cell line.
    Huber BE; Thorgeirsson SS
    Cancer Res; 1987 Jul; 47(13):3414-20. PubMed ID: 3034414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
    Su ZZ; Yemul S; Stein CA; Fisher PB
    Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated fos oncogene in rat embryo fibroblasts transformed by ras and myc oncogenes.
    Denner J; Jandrig B; Spitkovsky DD; Ehm I; Kisselyov FL; Schramm T
    Neoplasma; 1988; 35(3):263-70. PubMed ID: 3405335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proto-oncogene FGF-3 is constitutively expressed in tumorigenic, but not in non-tumorigenic, clones of a human colon carcinoma cell line.
    Galdemard C; Brison O; Lavialle C
    Oncogene; 1995 Jun; 10(12):2331-42. PubMed ID: 7784081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
    Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
    Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of transcriptional attenuation in N-myc is associated with progression towards a more malignant phenotype.
    Xu L; Meng Y; Wallen R; DePinho RA
    Oncogene; 1995 Nov; 11(9):1865-72. PubMed ID: 7478616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
    Marcotte R; Chen JM; Huard S; Wang E
    J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation.
    Greenberg RA; O'Hagan RC; Deng H; Xiao Q; Hann SR; Adams RR; Lichtsteiner S; Chin L; Morin GB; DePinho RA
    Oncogene; 1999 Feb; 18(5):1219-26. PubMed ID: 10022128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).
    Bader AG; Schneider ML; Bister K; Hartl M
    Oncogene; 2001 Nov; 20(51):7524-35. PubMed ID: 11709724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.